These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 23877683

  • 1. Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
    Hazirolan G, Canton E, Sahin S, Arikan-Akdagli S.
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4841-7. PubMed ID: 23877683
    [Abstract] [Full Text] [Related]

  • 2. In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens.
    Guinea J, Recio S, Escribano P, Peláez T, Gama B, Bouza E.
    Antimicrob Agents Chemother; 2010 Sep; 54(9):4012-5. PubMed ID: 20566770
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM.
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of isavuconazole against clinically relevant Trichosporon species: a comparative evaluation of EUCAST broth microdilution and MIC Test Strip methods.
    Francisco EC, Dieleman C, Hagen F, Colombo AL, Trichosporon Brazilian Network.
    J Antimicrob Chemother; 2023 Mar 02; 78(3):817-822. PubMed ID: 36702754
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
    Mariné M, Bom VL, de Castro PA, Winkelstroter LK, Ramalho LN, Brown NA, Goldman GH.
    Virulence; 2015 Mar 02; 6(5):476-86. PubMed ID: 25751127
    [Abstract] [Full Text] [Related]

  • 8. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
    Swinne D, Watelle M, Nolard N.
    Rev Iberoam Micol; 2005 Mar 02; 22(1):24-8. PubMed ID: 15813679
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species.
    Thompson GR, Wiederhold NP, Sutton DA, Fothergill A, Patterson TF.
    J Antimicrob Chemother; 2009 Jul 02; 64(1):79-83. PubMed ID: 19406849
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
    Espinel-Ingroff A.
    Rev Iberoam Micol; 2003 Dec 02; 20(4):121-36. PubMed ID: 15456349
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
    Uzun O, Arikan S, Kocagöz S, Sancak B, Unal S.
    Diagn Microbiol Infect Dis; 2000 Oct 02; 38(2):101-7. PubMed ID: 11035241
    [Abstract] [Full Text] [Related]

  • 14. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D, Coste AT.
    Antimicrob Agents Chemother; 2016 Jan 02; 60(1):229-38. PubMed ID: 26482310
    [Abstract] [Full Text] [Related]

  • 15. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A.
    J Clin Microbiol; 2001 Mar 02; 39(3):954-8. PubMed ID: 11230410
    [Abstract] [Full Text] [Related]

  • 16. In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
    Badali H, Khodavaisy S, Fakhim H, de Hoog GS, Meis JF, Chowdhary A.
    Antimicrob Agents Chemother; 2015 Dec 02; 59(12):7818-22. PubMed ID: 26369976
    [Abstract] [Full Text] [Related]

  • 17. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke P.
    Int J Antimicrob Agents; 2008 Dec 02; 32(6):511-4. PubMed ID: 18790613
    [Abstract] [Full Text] [Related]

  • 18. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
    Francisco EC, de Almeida Junior JN, de Queiroz Telles F, Aquino VR, Mendes AVA, de Andrade Barberino MGM, de Tarso O Castro P, Guimarães T, Hahn RC, Padovan ACB, Chaves GM, Colombo AL.
    Clin Microbiol Infect; 2019 Jul 02; 25(7):909.e1-909.e5. PubMed ID: 30991116
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of posaconazole and voriconazole in vitro killing against Candida krusei.
    Cantón E, Pemán J, Valentín A, Bosch M, Espinel-Ingroff A, Gobernado M.
    Diagn Microbiol Infect Dis; 2008 Oct 02; 62(2):177-81. PubMed ID: 18691842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.